Skip to content
★ Sign in to follow
1S

1. Sarah Hyman 2. Anita Hyman 3. Adam Hyman

Executive
Total declarations
1
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 30 Mar 2017 for BioPharma Credit PLC.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

1. Sarah Hyman 2. Anita Hyman 3. Adam Hyman: trading record in brief

Our data holds just one disclosure by 1. Sarah Hyman 2. Anita Hyman 3. Adam Hyman, dated 30 March 2017, reporting an open-market purchase in BioPharma Credit PLC. Further filings will be added here. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to 1. Sarah Hyman 2. Anita Hyman 3. Adam Hyman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Persons Closely Associated with Harry Hyman (Director of BioPharma Credit PLC)ExecutivesBioPharma Credit PLC
    0FCA-NSM
    6,000 sharesLondon Stock Exchange (XLON)ISIN GB00BDGKMY29FCA-NSM:LSE20170330130003_13177380_20200330131526802_24762
    Canonical exit: 28 Jun 2017 (T+90)

1 of 1 declaration